Upregulated YB-1 Protein Promotes Glioblastoma Growth Through a YB-1/CCT4/mLST8/mTOR Pathway
Jin-Zhu Wang,Hong Zhu,Pu You,Hui Liu,Wei-Kang Wang,Xiaojuan Fan,Yun Yang,Keren Xu,Yingfeng Zhu,Qunyi Li,Ping Wu,Chao Peng,Catherine C. L. Wong,Kaicheng Li,Yufeng Shi,Nu Zhang,Xiuxing Wang,Rong Zeng,Ying Huang,Liusong Yang,Zefeng Wang,Jingyi Hui
DOI: https://doi.org/10.1172/jci146536
2022-01-01
Abstract:Y-box-binding protein 1 (YB-1) is a multifunctional RNA binding protein involved in virtually every step of RNA metabolism. However, the functions and mechanisms of YB-1 in one of the most aggressive cancers, glioblastoma, are not well understood. In this study, we found that YB-1 protein was markedly overexpressed in glioblastoma and acted as a critical activator of both mTORC1 and mTORC2 signaling. Mechanistically, YB-1 bound the 5'UTR of CCT4 mRNA to promote the translation of CCT4, a component of the CCT chaperone complex, that in turn activated the mTOR signaling pathway by promoting mLST8 folding. In addition, YB-1 autoregulated its own translation by binding to its 5'UTR, leading to sustained activation of mTOR signaling. In patients with glioblastoma, high protein expression of YB-1 correlated with increased expression of CCT4 and mLST8 and activated mTOR signaling. Importantly, the administration of RNA decoys specifically targeting YB-1 in a mouse xenograft model resulted in slower tumor growth and better survival. Taken together, these findings uncover a disrupted proteostasis pathway involving a YB-1/CCT4/mLST8/mTOR axis in promoting glioblastoma growth, suggesting that YB-1 is a potential therapeutic target for the treatment of glioblastoma.